Jiuzhou Pharmaceutical(SH:603456) Zheng Quan Zhi Xing·2025-06-25 17:34Core Viewpoint - Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has decided to change the purpose of its share repurchase plan from "for future implementation of equity incentive plans" to "for cancellation and reduction of registered capital" by canceling 5,789,800 shares from its repurchased stock account [1][3]. Group 1: Share Repurchase Plan - The company proposed a share repurchase plan on December 26, 2023, to buy back shares using its own funds through centralized bidding, initially intended for equity incentive or employee stock ownership plans [1]. - On January 4, 2024, the board approved the repurchase plan, allowing the company to buy back shares at a price not exceeding RMB 36 per share, with a total repurchase amount between RMB 50 million and RMB 100 million within 12 months [2]. - The actual repurchase was completed, with a total of 5,789,800 shares bought back, accounting for 0.65% of the company's total share capital, with a total expenditure of approximately RMB 99.89 million [2][3]. Group 2: Share Cancellation Details - The company plans to cancel the repurchased shares and reduce its registered capital accordingly, with the cancellation process having been approved in board meetings held on April 10 and May 8, 2025 [3]. - The cancellation of 5,789,800 shares will reduce the total share capital from 895,235,828 shares to 889,446,028 shares, maintaining the same percentage of unlimited sale shares at 100% [5]. - The company has completed the necessary creditor notification procedures, and no claims or guarantees were requested by creditors during the public notice period [3].